NuCana plc - American Depositary Shares (NQ:NCNA)

1.090 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NuCana plc - American Depositary Shares

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Top movers in Monday's session ↗

May 05, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.

Via Chartmill

These stocks are gapping in today's session ↗

May 05, 2025

The market is buzzing with gapping stocks on Monday. Let's uncover which stocks are experiencing notable gaps during today's session.

Via Chartmill

Nasdaq Falls Over 100 Points; Tyson Foods Posts Downbeat Sales ↗

May 05, 2025

Via Benzinga

These stocks that are showing activity before the opening bell on Monday. ↗

May 05, 2025

Discover the top movers in Monday's pre-market session and stay informed about market dynamics.

Via Chartmill

NCNA Stock Earnings: NuCana Beats EPS for Q2 2024 ↗

August 15, 2024

NCNA stock results show that NuCana beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

May 05, 2025

Via Benzinga

Why Faraday Future Intelligent Electric Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗

May 05, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 29, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 24, 2025

Via Benzinga

NCNA Stock Earnings: NuCana Beats EPS for Q1 2024 ↗

May 16, 2024

NCNA stock results show that NuCana beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Dow Jumps Over 200 Points; PepsiCo Cuts Earnings Outlook ↗

April 24, 2025

Via Benzinga

Topics Stocks

NuCana Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update

March 20, 2025

From NuCana plc

Via GlobeNewswire

NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update

November 25, 2024

From NuCana plc

Via GlobeNewswire

NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel

November 11, 2024

From NuCana plc

Via GlobeNewswire

Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket ↗

September 26, 2024

Via Benzinga

NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States

September 25, 2024

From NuCana plc

Via GlobeNewswire

Crude Oil Surges Over 1%; Instil Bio Shares Plunge ↗

September 16, 2024

Via Benzinga

Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September ↗

September 16, 2024

Via Benzinga

Topics Stocks

NuCana Resistant Melanoma Treatment Data Shows Providing Some Relief After Disappointing Colorectal Cancer Data, Stock Surges ↗

September 16, 2024

NuCana presented final data from a Phase 2 study at ESMO Congress, showing NUC-7738 combined with Keytruda achieved a 75% disease control rate in metastatic melanoma patients resistant to prior PD-1...

Via Benzinga

Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket ↗

September 16, 2024

Via Benzinga

NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024

September 14, 2024

Combination of NUC-7738 plus Pembrolizumab Resulted in Prolonged Progression Free Survival, a Compelling Disease Control Rate including Partial Responses, and a Favorable Safety Profile

From NuCana plc

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 02, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 02, 2024

Via Benzinga

NuCana Stock Plunges On Colorectal Combo Therapy Trial Setback, Ends Mid-Stage Study After Disappointing Data ↗

August 30, 2024

NuCana will discontinue the NuTide:323 study after an initial analysis recommended by the Steering Committee, as the combination treatment was unlikely to achieve superior Progression-Free Survival...

Via Benzinga

NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study

August 29, 2024

From NuCana plc

Via GlobeNewswire

Why Bit Digital Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket ↗

August 20, 2024

Via Benzinga

NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update

August 15, 2024

From NuCana plc

Via GlobeNewswire

NuCana to Present at the Jefferies Global Healthcare Conference

May 30, 2024

From NuCana plc

Via GlobeNewswire

NuCana to Present at TD Cowen’s 5th Annual Oncology Innovation Summit

May 21, 2024

From NuCana plc

Via GlobeNewswire

NuCana Reports First Quarter 2024 Financial Results and Provides Business Update

May 16, 2024

From NuCana plc

Via GlobeNewswire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.